ImmunoMet
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
9
Total Funding
$42.9M
Investors
9 investors across all rounds
GT
G.N. Tech Venture Capital
HB
Hanall Biopharma
IC
Incon Company
I
InterVest
VENTURE_CAPITAL
JJ
Johnson & Johnson Innovation - JLABS
Explore More Data
Detailed analysis for ImmunoMet
ImmunoMet Leadership & Investors
ImmunoMet is led by a team of experienced leaders. The company has attracted investment from 9 institutional and strategic investors.
Who Has Invested in ImmunoMet?
ImmunoMet has raised $42.9M from 9 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access ImmunoMet shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.